查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
耳鼻喉设备市场：按产品、最终用户分类，预测 2023-2032 年
市场调查报告书
商品编码
1264992

耳鼻喉设备市场：按产品、最终用户分类，预测 2023-2032 年

ENT Devices Market - By Product, By End-use & Forecast, 2023 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 330 Pages | 商品交期: 2-3个工作天内

价格
简介目录

在耳鼻喉设备技术创新进步的推动下，预计到 2032 年全球耳鼻喉设备市场将实现显着增长。

此外，该领域的参与者专注于设计具有集成功能的助听器，帮助用户跟踪他们的认知听力。 例如，2022 年 11 月，医疗设备公司 Cochlear 将为其 Nucleus 8 声音处理器（最小的耳后式人工耳蜗声音处理器）提供与日常消费电子产品的直接蓝牙连接，并获得美国 FDA 批准。

总体而言，耳鼻喉设备行业根据产品、最终用途和地理位置进行细分。

按产品划分，耳鼻喉科手术设备市场将增长预计到 2020 年将实现显着增长。 据美国癌症协会估计，仅在 2023 年，美国就将诊断出约 54,540 例口咽癌新病例。 此外，图像引导手术系统等手术设备的最新进展扩大了它们在耳鼻喉科的应用，为细分市场的增长提供了有利可图的机会。

由于对先进手术和诊断的需求不断增长，预计到 2032 年，耳鼻喉诊所领域的耳鼻喉设备行业的最终用途估值将超过 70 亿美元。事实一直如此。 这些设施配备了先进的诊断设备和熟练的医务人员，导致患者人数不断增加。 此外，世界各国政府都在大力投资耳鼻喉科诊所，这也推动了该行业的增长。

按地区划分，欧洲耳鼻喉设备市场到 2022 年将超过 60 亿美元。 耳鼻喉疾病的日益流行增加了该地区对耳鼻喉设备的需求。 据世卫组织称，世卫组织欧洲区域有超过 1.9 亿人患有不同程度的听力损失。

此外，Sonova Holding AG 和 Lumenis Be Ltd 等主要行业领导者不断致力于新产品创新，进一步推动区域扩张。 例如，2023 年 1 月，瑞士听力保健解决方案提供商 Sonova Holding AG 将推出 Sennheiser Conversation Clear Plus 耳塞，这是一种全新的语音增强耳戴式解决方案，可帮助用户提高在嘈杂环境中的理解力。 通过这次发布，该公司建立了一个新的早期进入者听力解决方案类别。

内容

第一章调查方法及范围

第 2 章执行摘要

第 3 章：耳鼻喉设备行业洞察

  • 行业格局，2018-2032 年版
  • 影响行业的因素
    • 司机
      • 耳鼻喉疾病的全球流行率上升
      • 全球老龄化人口不断增加
      • 耳鼻喉科设备技术进步
      • 对微创耳鼻喉科手术的需求不断增长
    • 行业潜在的风险和挑战
      • 高昂的程序和设备成本
      • 世界各地的社会耻辱
  • 增长分析
    • 按产品类型
    • 按最终用途
  • COVID-19 影响分析
  • 监管状况
    • 美国
    • 欧洲
  • 技术概况
  • 赎回场景
    • 美国
    • 欧洲
  • 未来的市场趋势
  • 差距分析
  • 价值链分析
  • 波特分析
  • PESTEL 分析

第 4 章竞争格局，2022 年

  • 简介
  • 公司矩阵分析，2022 年
  • 战略仪表板，2022 年

第 5 章耳鼻喉设备市场，按产品类型分类

  • 主要产品类型的趋势
  • 耳鼻喉科诊断设备
    • 硬性内窥镜
      • 鼻窥镜
      • 会厌范围
      • 耳鼻喉科内窥镜
    • 软性内窥镜
    • 机器人辅助内窥镜
    • 听力筛查设备
  • 耳鼻喉科手术器械
    • 无线电波手机
    • 电动手术器械
    • 耳科钻孔器
    • 耳鼻喉手持器械
    • 鼓膜切开管
    • 鼻窦扩张器
    • 鼻腔填塞装置
  • 助听器
    • 年度最佳 (BTE)
    • 在运河中完成/在运河中隐形 (CIC/IIC)
    • 在运河 (ITC)
    • 年度 (ITE)
    • 耳式接收器/耳道式接收器 (RITE/RIC)
  • 听力障碍植入物
    • 听觉脑干植入物
    • 人工耳蜗
    • 中耳植入物
    • 骨锚式助听器
  • 语音合成设备
  • 鼻夹板
    • 鼻内夹板
    • 外鼻夹板

第 6 章 ENT 设备市场：按最终用户分类

  • 主要的最终用户趋势
  • 医院
  • 门诊手术中心 (ASC)
  • 耳鼻喉科诊所
  • 家庭护理

第 7 章 ENT 设备市场：按地区

  • 主要区域趋势
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 波兰
    • 瑞典
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 韩国
    • 印度尼西亚
    • 菲律宾
    • 越南
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 智利
    • 秘鲁
  • 多边环境协定
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其人
    • 埃及

第八章公司简介

  • DeSoutter Medical
  • Johnson & Johnson
  • Medtronic plc
  • Stryker Corporation
  • Zimmer Biomet
  • Olympus Corporation
  • WestCMR
  • Smith & Nephew plc
  • Nouvag AG
  • Vega Medical
  • Atos Medical
  • Boston Scientific Corporation
  • Cochlear
  • Lumenis Be Ltd
  • Meril Life Sciences Pvt. Ltd
  • Narang Medical Limited.
  • Sonova Group
  • Welch Allyn
简介目录
Product Code: 496

Global ENT devices market is slated to record substantial gains through 2032, pushed by the growing technological innovations in ENT devices. Moreover, players in the field have been focusing on devising hearing aids with integration capabilities to help users track their cognitive hearing. Citing an instance, in November 2022, Cochlear, a medical device company, received U.S. FDA clearance for its Nucleus® 8 Sound Processor, the smallest behind-the-ear cochlear implant sound processor, offering direct connectivity to daily consumer electronics via Bluetooth.

Overall, the ENT devices industry is segmented in terms of product, end-use, and region.

On the basis of product, the ENT devices market from the surgical ENT devices segment is poised to register noteworthy gains through 2032, owing to the growing occurrence of ENT disorders such as oral cancer, temporal bone cancer, and others that require surgeries for treatment. As per the American Cancer Society, in 2023, around 54,540 new cases of oropharyngeal cancer are estimated to be diagnosed in the U.S. alone. Furthermore, recent advancements in surgical equipment, such as image-guided surgery systems, have increased their applications in otorhinolaryngology, presenting lucrative opportunities for segment growth.

In terms of end-use, the ENT devices industry from the ENT clinics segment is anticipated to record a valuation of over USD 7 billion by 2032 on account of rising demand for advanced surgical and diagnostic procedures. These facilities also have strong availability of advanced diagnostic devices and skilled healthcare professionals resulting in increased patient footfall. Moreover, governments across the globe are investing ample amounts in ENT clinics, which is further set to augment segment growth.

From the regional perspective, the Europe ENT devices market garnered over USD 6 billion in 2022. The growing prevalence of ENT disorders has accentuated the need for ENT devices in the region. As per WHO, more than 190 million people in the WHO European Region have some degree of hearing loss.

Moreover, the robust presence of major industry leaders such as Sonova Holding AG, Lumenis Be Ltd, and others constantly indulging in innovating new products is also fueling regional expansion. For instance, in January 2023, Sonova Holding AG, a Swiss hearing care solutions provider, announced the launch of Sennheiser Conversation Clear Plus earbuds, new speech-enhanced hearable solutions to help users improve their comprehension in loud environments. This launch helped the company establish a new category of early-entry hearing solutions.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Industry coverage
  • 1.2 Market scope & definitions
  • 1.3 Base estimates & working
    • 1.3.1 Data collection
  • 1.4 Forecast parameters
  • 1.5 COVID-19 impact analysis at global level
  • 1.6 Data validation
  • 1.7 Data sources
    • 1.7.1 Primary
    • 1.7.2 Secondary
      • 1.7.2.1 Paid sources
      • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 ENT devices industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Product type trends
    • 2.1.3 End-use trends
    • 2.1.4 Regional trends

Chapter 3 ENT Devices Industry Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of ENT disorders globally
      • 3.2.1.2 Increasing geriatric population globally
      • 3.2.1.3 Technological advancements in the ENT devices
      • 3.2.1.4 Rising demand for minimally invasive ENT procedures
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High procedure and instruments cost
      • 3.2.2.2 Social stigma across the globe
  • 3.3 Growth potential analysis
    • 3.3.1 By product type
    • 3.3.2 By end-use
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
    • 3.5.1 U.S.
    • 3.5.2 Europe
  • 3.6 Technology landscape
  • 3.7 Reimbursement scenario
    • 3.7.1 U.S.
    • 3.7.2 Europe
  • 3.8 Future market trends
  • 3.9 Gap analysis
  • 3.10 Value-chain analysis
  • 3.11 Porter's analysis
  • 3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Strategy dashboard, 2022

Chapter 5 ENT Devices Market, By Product Type

  • 5.1 Key product type trends
  • 5.2 Diagnostic ENT Devices
    • 5.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.2.2 Rigid Endoscopes
      • 5.2.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
      • 5.2.2.2 Rhinoscopes
        • 5.2.2.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
      • 5.2.2.3 Laryngoscopes
        • 5.2.2.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
      • 5.2.2.4 Otological Endoscopes
        • 5.2.2.4.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.2.3 Flexible Endoscopes
      • 5.2.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.2.4 Robot Assisted Endoscopes
      • 5.2.4.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.2.5 Hearing Screening Device
      • 5.2.5.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
  • 5.3 Surgical ENT Devices
    • 5.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.3.2 Radiofrequency Handpieces
      • 5.3.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.3.3 Powered Surgical Instrument
      • 5.3.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.3.4 Otological Drill Burrs
      • 5.3.4.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.3.5 ENT Hand Instruments
      • 5.3.5.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.3.6 Tympanostomy Tubes
      • 5.3.6.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.3.7 Sinus Dilation Devices
      • 5.3.7.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.3.8 Nasal Packing Devices
      • 5.3.8.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
  • 5.4 Hearing Aids
    • 5.4.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.4.2 Behind-the-ear (BTE)
      • 5.4.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.4.3 Completely-in-the-canal/Invisible-in-canal (CIC/IIC)
      • 5.4.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.4.4 In-the-canal (ITC)
      • 5.4.4.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.4.5 In-the-ear (ITE)
      • 5.4.5.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.4.6 Receiver in the ear/Receiver in Canal (RITE/RIC)
      • 5.4.6.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
  • 5.5 Hearing Implants
    • 5.5.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.5.2 Auditory Brainstem Implants
      • 5.5.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.5.3 Cochlear Implants
      • 5.5.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.5.4 Middle Ear Iimplants
      • 5.5.4.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.5.5 Bone Anchored Hearing System
      • 5.5.5.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
  • 5.6 Voice Prosthesis Devices
    • 5.6.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
  • 5.7 Nasal Splints
    • 5.7.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.7.2 Internal Nasal Splints
      • 5.7.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.7.3 External Nasal Splints
      • 5.7.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)

Chapter 6 ENT Devices Market, By End-use

  • 6.1 Key end-use trends
  • 6.2 Hospitals
    • 6.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
  • 6.3 Ambulatory surgical centers (ASCs)
    • 6.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
  • 6.4 ENT Clinics
    • 6.4.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
  • 6.5 Homecare
    • 6.5.1 Market estimates and forecasts, 2018 - 2032 (USD Million)

Chapter 7 ENT Devices Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Poland
    • 7.3.7 Sweden
    • 7.3.8 The Netherlands
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Indonesia
    • 7.4.7 Philippines
    • 7.4.8 Vietnam
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Columbia
    • 7.5.5 Chile
    • 7.5.6 Peru
  • 7.6 MEA
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE
    • 7.6.4 Israel
    • 7.6.5 Turkey
    • 7.6.6 Egypt

Chapter 8 Company Profiles

  • 8.1 DeSoutter Medical
  • 8.2 Johnson & Johnson
  • 8.3 Medtronic plc
  • 8.4 Stryker Corporation
  • 8.5 Zimmer Biomet
  • 8.6 Olympus Corporation
  • 8.7 WestCMR
  • 8.8 Smith & Nephew plc
  • 8.9 Nouvag AG
  • 8.10 Vega Medical
  • 8.11 Atos Medical
  • 8.12 Boston Scientific Corporation
  • 8.13 Cochlear
  • 8.14 Lumenis Be Ltd
  • 8.15 Meril Life Sciences Pvt. Ltd
  • 8.16 Narang Medical Limited.
  • 8.17 Sonova Group
  • 8.18 Welch Allyn